Halozyme Therapeutics shares owned by Cetera Investment Advisers
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Cetera Investment Advisers
from 13F filings
Historical chart of Cetera Investment Advisers investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by Cetera Investment Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $3.5M | 54k | 64.63 |
| 2025-12-31 | $3.7M | 55k | 67.30 |
| 2025-09-30 | $4.4M | 60k | 73.34 |
| 2025-06-30 | $2.4M | 46k | 52.02 |
| 2025-03-31 | $2.9M | 45k | 63.81 |
| 2024-12-31 | $2.0M | 42k | 47.81 |
| 2024-09-30 | $2.2M | 39k | 57.24 |
| 2024-06-30 | $1.4M | 28k | 52.36 |
| 2024-03-31 | $772k | 19k | 40.68 |
More positions owned by Cetera Investment Advisers
View all positions for Cetera Investment Advisers